Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry

Journal of Proteomics

Volumn 76, Issue , 2012, Pages 141-149

  Mathivanan, Suresh ^a,b   Ji, Hong ^a,b   Tauro, Bow J ^a,b   Chen, Yuan Shou ^b,c   Simpson, Richard J ^a,b  

^a LA TROBE UNIVERSITY   (Australia)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

CRC specific biomarkers; Integrated genomics and proteomics; Plasma biomarkers; Protein mutation

Indexed keywords

COMPLEMENTARY DNA; PEPTIDE; RNA; SECRETOME; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; COLON CANCER; DNA SEQUENCE; GENE MUTATION; GENOMICS; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

CELL LINE, TUMOR; COLONIC NEOPLASMS; DATABASES, PROTEIN; HUMANS; MASS SPECTROMETRY; MUTATION; NEOPLASM PROTEINS; PROTEOME; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84869886372     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.06.031     Document Type: Article

References (44)

1. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., et al. Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
2. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
3. Teschendorff A.E., Caldas C. The breast cancer somatic 'muta-ome': tackling the complexity. Breast Cancer Res 2009, 11:301.
4. Bozic I., Antal T., Ohtsuki H., Carter H., Kim D., Chen S., et al. Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A 2010, 107:18545-18550.
5. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458:719-724.
6. Wang Q., Chaerkady R., Wu J., Hwang H.J., Papadopoulos N., Kopelovich L., et al. Mutant proteins as cancer-specific biomarkers. Proc Natl Acad Sci U S A 2011, 108:2444-2449.
7. Ma P.C., Zhang X., Wang Z.J. High-throughput mutational analysis of the human cancer genome. Pharmacogenomics 2006, 7:597-612.
8. Calvert P.M., Frucht H. The genetics of colorectal cancer. Ann Intern Med 2002, 137:603-612.
9. Nakamura Y., Nishisho I., Kinzler K.W., Vogelstein B., Miyoshi Y., Miki Y., et al. Mutations of the adenomatous polyposis coli gene in familial polyposis coli patients and sporadic colorectal tumors. Princess Takamatsu Symp 1991, 22:285-292.
10. Wheeler J.M., Bodmer W.F., Mortensen N.J. DNA mismatch repair genes and colorectal cancer. Gut 2000, 47:148-153.
11. Laken S.J., Petersen G.M., Gruber S.B., Oddoux C., Ostrer H., Giardiello F.M., et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997, 17:79-83.
12. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
13. Forbes S.A., Bindal N., Bamford S., Cole C., Kok C.Y., Beare D., et al. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res 2011, 39:D945-D950.
14. Strom C.M. Mutation detection, interpretation, and applications in the clinical laboratory setting. Mutat Res 2005, 573:160-167.
15. Wang Z., Shen D., Parsons D.W., Bardelli A., Sager J., Szabo S., et al. Mutational analysis of the tyrosine phosphatome in colorectal cancers. Science 2004, 304:1164-1166.
16. Bardelli A., Parsons D.W., Silliman N., Ptak J., Szabo S., Saha S., et al. Mutational analysis of the tyrosine kinome in colorectal cancers. Science 2003, 300:949.
17. Picotti P., Rinner O., Stallmach R., Dautel F., Farrah T., Domon B., et al. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods 2010, 7:43-46.
18. Klein-Scory S., Kubler S., Diehl H., Eilert-Micus C., Reinacher-Schick A., Stuhler K., et al. Immunoscreening of the extracellular proteome of colorectal cancer cells. BMC Cancer 2010, 10:70.
19. Pavlou M.P., Diamandis E.P. The cancer cell secretome: a good source for discovering biomarkers?. J Proteomics 2010, 10:1896-1906.
20. Wu C.C., Chen H.C., Chen S.J., Liu H.P., Hsieh Y.Y., Yu C.J., et al. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 2008, 8:316-332.
21. Xue H., Lu B., Zhang J., Wu M., Huang Q., Wu Q., et al. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res 2010, 9:545-555.
22. Zhang H.H., Walker F., Kiflemariam S., Whitehead R.H., Williams D., Phillips W.A., et al. Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B-Raf. Int J Cancer 2009, 125:297-307.
23. Whitehead R.H., Zhang H.H., Hayward I.P. Retention of tissue-specific phenotype in a panel of colon carcinoma cell lines: relationship to clinical correlates. Immunol Cell Biol 1992, 70(Pt 4):227-236.
24. Simpson R.J., Connolly L.M., Eddes J.S., Pereira J.J., Moritz R.L., Reid G.E. Proteomic analysis of the human colon carcinoma cell line (LIM 1215): development of a membrane protein database. Electrophoresis 2000, 21:1707-1732.
25. Mathivanan S., Lim J.W., Tauro B.J., Ji H., Moritz R.L., Simpson R.J. Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics 2010, 9:197-208.
26. Chen Y.S., Mathias R.A., Mathivanan S., Kapp E.A., Moritz R.L., Zhu H.J., et al. Proteomics profiling of Madin-Darby canine kidney plasma membranes reveals Wnt-5a involvement during oncogenic H-Ras/TGF-beta-mediated epithelial-mesenchymal transition. Mol Cell Proteomics 2011, 10. (M110.001131).
27. Pruitt K.D., Tatusova T., Maglott D.R. NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 2007, 35:D61-D65.
28. UniProt-Consortium The Universal Protein Resource (UniProt) in 2010. Nucleic Acids Res 2010, 38:D142-D148.
29. Amberger J., Bocchini C.A., Scott A.F., Hamosh A. McKusick's Online Mendelian Inheritance in Man (OMIM). Nucleic Acids Res 2009, 37:D793-D796.
30. Xi H., Park J., Ding G., Lee Y.H., Li Y. SysPIMP: the web-based systematical platform for identifying human disease-related mutated sequences from mass spectrometry. Nucleic Acids Res 2009, 37:D913-D920.
31. Sherry S.T., Ward M.H., Kholodov M., Baker J., Phan L., Smigielski E.M., et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001, 29:308-311.
32. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
33. Bendtsen J.D., Nielsen H., von Heijne G., Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004, 340:783-795.
34. Hiller K., Grote A., Scheer M., Munch R., Jahn D. PrediSi: prediction of signal peptides and their cleavage positions. Nucleic Acids Res 2004, 32:W375-W379.
35. Kall L., Krogh A., Sonnhammer E.L. A combined transmembrane topology and signal peptide prediction method. J Mol Biol 2004, 338:1027-1036.
36. Smedley D., Haider S., Ballester B., Holland R., London D., Thorisson G., et al. BioMart-biological queries made easy. BMC Genomics 2009, 10:22.
37. Mathivanan S., Fahner C.J., Reid G.E., Simpson R.J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012, 40:D1241-D1244.
38. Mathivanan S., Ahmed M., Ahn N.G., Alexandre H., Amanchy R., Andrews P.C., et al. Human Proteinpedia enables sharing of human protein data. Nat Biotechnol 2008, 26:164-167.
39. Mishra G.R., Suresh M., Kumaran K., Kannabiran N., Suresh S., Bala P., et al. Human protein reference database-2006 update. Nucleic Acids Res 2006, 34:D411-D414.
40. Borrell B. How accurate are cancer cell lines?. Nature 2010, 463:858.
41. Slebos R.J., Brock J.W., Winters N.F., Stuart S.R., Martinez M.A., Li M., et al. Evaluation of strong cation exchange versus isoelectric focusing of peptides for multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res 2008, 7:5286-5294.
42. Hill J.A., Smith B.E., Papoulias P.G., Andrews P.C. ProteomeCommons.org collaborative annotation and project management resource integrated with the tranche repository. J Proteome Res 2010, 6:2809-2811.
43. Mathivanan S., Pandey A. Human Proteinpedia as a resource for clinical proteomics. Mol Cell Proteomics 2008, 7:2038-2047.
44. Deutsch E.W. The PeptideAtlas Project. Methods Mol Biol 2010, 604:285-296.